Home   >  
Neuro Signaling Pathway
  >  
P glycoprotein
  >   Zosuquidar 3HCl
Zosuquidar 3HCl Chemical Structure

Zosuquidar 3HCl

Data Sheet For research use only. Not for human use.
Cat. No. :BCP02954CAS No. :167465-36-3Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 167465-36-3 Cat. No. BCP02954
Name Zosuquidar 3HCl
Synonyms LY335979;RS 33295-198; Zosuquidar trihydrochloride;LY335979;LY-335979;
SMILES
Chemical Name
Formula C32H31F2N3O2.3HCl M. Wt 636.99
Purity 98% Storage Store at 4-8°C
Description LY335979 competitively inhibits equilibrium binding of vinblastine to Pgp by blocking azidopine photoaffinity labeling of the Pgp in CEM/VLB100 plasma membranes.LY335979 alone shows the cytotoxicity to drug-sensitive and MDR cell lines with IC50 ranging from 6 μM-16 μM and produces its ability to completely reverse the resistance of the oncolytics (vinblastine, doxorubicin, or etoposide) to the MDR cell lines P388/ADR, MCF7/ADR, 2780AD, or UCLA-P3.003VLB at concentration of 0.1 and 0.5 μM. LY335979 significantly restores drug sensitivity in P-gp-expressing leukemia cell lines including K562/HHT40, K562/HHT90, K562/DOX and HL60/DNR, and enhances the cytotoxicity of anthracyclines (daunorubicin, idarubicin, mitoxantrone) and gemtuzumab ozogamicin (Mylotarg) in primary AML blasts with active P-gp. A latest paper indicates that LY335979 completely inhibits apically directed transport of (Z)-endoxifen in the ABCB1-transduced cells.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Zosuquidar 3HCl supplier,Zosuquidar 3HCl purchase,Zosuquidar 3HCl manufacturer,Zosuquidar 3HCl distributor,Zosuquidar 3HCl cost,Zosuquidar 3HCl buy,Zosuquidar 3HCl for sale

0086-13720134139